Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Scarpignato

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Pharmacological Research|January 8, 2016
Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting systemConcetta Rafaniello, Carmen Ferrajolo, Maria Giuseppa Sullo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 5, 2019
Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)Sara Montagnese, Francesco Paolo Russo, Piero Amodio, et al.
Digestive Diseases (Basel, Switzerland)|March 24, 2026
Self-management of reflux-like symptoms: A patient-centered decision-making approachA Pali S Hungin, Carmelo Scarpignato, Albert J Bredenoord, et al.
Internal and Emergency Medicine|August 20, 2010
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant populationLuigi Gatta, Francesco Di Mario, Dino Vaira, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|January 14, 2020
Hot Topics in Medical Treatment of Diverticular Disease: Evidence Pro and ConsGiovanni Brandimarte, Mauro Bafutto, Wolfgang Kruis, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2013
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?Matteo Fornai, Luca Antonioli, Rocchina Colucci, et al.
Pharmacological Research|January 10, 2016
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibioticMatteo Fornai, Luca Antonioli, Carolina Pellegrini, et al.
Internal and Emergency Medicine|June 8, 2024
Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitionersLuigi Gatta, Massimo Bellini, Carmelo Scarpignato, et al.
European Journal of Gastroenterology & Hepatology|January 12, 2026
Empirical first- and second-line eradication regimens for Helicobacter pylori adult-infected patients: a National Survey among Italian gastroenterologists and general practitionersLuigi Gatta, Carmelo Scarpignato, Angelo Zullo, et al.
Annals of the New York Academy of Sciences|October 1, 2014
Benign and precursor lesions in the esophagusJunichi Akiyama, Anna Bertelé, Christina Brock, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Pharmacological Research|January 8, 2016
Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting systemConcetta Rafaniello, Carmen Ferrajolo, Maria Giuseppa Sullo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 5, 2019
Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)Sara Montagnese, Francesco Paolo Russo, Piero Amodio, et al.
Digestive Diseases (Basel, Switzerland)|March 24, 2026
Self-management of reflux-like symptoms: A patient-centered decision-making approachA Pali S Hungin, Carmelo Scarpignato, Albert J Bredenoord, et al.
Internal and Emergency Medicine|August 20, 2010
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant populationLuigi Gatta, Francesco Di Mario, Dino Vaira, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|January 14, 2020
Hot Topics in Medical Treatment of Diverticular Disease: Evidence Pro and ConsGiovanni Brandimarte, Mauro Bafutto, Wolfgang Kruis, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2013
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?Matteo Fornai, Luca Antonioli, Rocchina Colucci, et al.
Pharmacological Research|January 10, 2016
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibioticMatteo Fornai, Luca Antonioli, Carolina Pellegrini, et al.
Internal and Emergency Medicine|June 8, 2024
Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitionersLuigi Gatta, Massimo Bellini, Carmelo Scarpignato, et al.
European Journal of Gastroenterology & Hepatology|January 12, 2026
Empirical first- and second-line eradication regimens for Helicobacter pylori adult-infected patients: a National Survey among Italian gastroenterologists and general practitionersLuigi Gatta, Carmelo Scarpignato, Angelo Zullo, et al.
Annals of the New York Academy of Sciences|October 1, 2014
Benign and precursor lesions in the esophagusJunichi Akiyama, Anna Bertelé, Christina Brock, et al.
Pageof 13